A Systematic Review and Illustrative Case Presentation of Low-Grade Myofibroblastic Sarcoma (LGMS) of the Extremities

Author:

Schenker Astrid1,Gutjahr Ewgenija2ORCID,Lehner Burkhard1,Mechtersheimer Gunhild2,Wardelmann Eva3ORCID,Klotz Rosa45ORCID,Kalkum Eva4,Schiltenwolf Marcus1ORCID,Harhaus Leila1,Renkawitz Tobias1,Panzram Benjamin1

Affiliation:

1. Department for Orthopaedics, University of Heidelberg, Schlierbacher Landstraße 200a, 69118 Heidelberg, Germany

2. Department of Pathology, University of Heidelberg, 69120 Heidelberg, Germany

3. Gerhard Domagk Institute of Pathology, University Hospital Muenster, Albert-Schweitzer-Campus 1, Building D17, 48149 Muenster, Germany

4. Study Center of the German Society of Surgery (SDGC), University of Heidelberg, Im Neuenheimer Feld 130.3, 69120 Heidelberg, Germany

5. Department of General, Visceral and Transplantation Surgery, Heidelberg University Hospital, 69118 Heidelberg, Germany

Abstract

Introduction: Low-grade myofibroblastic sarcoma (LGMS) is a rare tumor entity which occurs in the subcutaneous and deep soft tissues; it is less common in the bone with a predilection for the extremities and the head and neck region. As confirming the diagnosis is difficult and treatment strategies are not standardized, we aimed to identify patient and tumor characteristics, and to summarize treatment strategies and their clinical outcomes to guide surgeons. Methods: Included were full articles reporting patients with histology of LGMS in the extremities, excluding tumors of the trunk. All patients underwent surgery but with different extend, from marginal to wide resection. Included studies should inform about local recurrence, metastasis, or evidence of disease, depending on the surgical treatment. We conducted a structured search using MEDLINE (via PubMed), Web of Science, EMBASE and Cochrane Central Register of Controlled Trials (CENTRAL) to identify studies on low-grade myofibroblastic sarcoma of the extremities. Study designs like randomized controlled trials, systematic reviews, prospective trials, retrospective studies, and case reports were included. Prospective studies and comparative studies were not available at all. Therefore, meta-analysis was not possible and statistical analysis was purely descriptive. Results: Of the 789 studies identified from our initial search, 17 studies including 59 cases reported LGMS of the extremities with the surgical treatment and clinical outcome and were therefore analyzed. In addition, we present the rare case and surgical management of a 28-year-old male patient with residual LGMS of the thumb after an initial incomplete resection. The current literature suggests that a wide excision with R0 margins should be considered the standard treatment for LGMS. In cases where surgery leads to significant functional impairment, individual options like free tissue transfer from a donor site have to be considered. Therefore, we also present an illustrative case. For all selected case series and case reports, a high risk of confounding, selection bias, information bias, and reporting bias must be anticipated. Nevertheless, this systematic review provides a comprehensive overview on surgical treatment and clinical outcomes in LGMS surgery of the extremities.

Publisher

MDPI AG

Subject

General Medicine

Reference50 articles.

1. A sarcoma of myofibroblasts: An ultrastructural study;Vasudev;Arch. Pathol. Lab. Med.,1978

2. WHO Classification of Tumours Editorial Board (2020). WHO Classification of Tumours: Soft Tissue and Bone Tumours, International Agency for Research on Cancer, IARD Press.

3. Low-grade myofibroblastic sarcoma: Analysis of 18 cases in the spectrum of myofibroblastic tumors;Mentzel;Am. J. Surg. Pathol.,1998

4. Low-grade myofibroblastic sarcoma: A population-based study;Chan;Laryngoscope,2017

5. The myofibroblast: A quarter century after its discovery;Schurch;Am. J. Surg. Pathol.,1998

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3